Skip Navigation

Profile

Doris Renee Brown, M.D., Ph.D.Wake Forest Baptist Health

Doctor Rating

4.5 out of 5

90 Ratings
5 Comments
 

Doris Renee Brown, M.D., Ph.D.

Assistant Professor,

Clinical Interests

Sarcoma, Hematologic Malignancies, Breast Cancer

Contact Information

Returning Patient Appointments: 336-713-3600
Department: 336-713-3600

Email: drbrown@wakehealth.edu

Insurance Accepted »

Education & Training

  • M.D., WFU School of Medicine, 2006
  • Internship, Internal Medicine, Univ Hosp (U Of Michigan), 2007
  • Residency, Radiation Oncology, Univ Hosp (U Of Michigan), 2011

Board Certifications

  • American Board of Radiology, Radiation Oncology

Memberships

  • Am Assn Of Women Radiologists
  • Radiological Soc of North Amer
  • Am Soc for Radiation Oncology
  • Am Soc of Clinical Oncology

NPI Number

  • 1326165663
Doris Renee Brown, M.D., Ph.D.

Doctor Rating

4.5 out of 5

90 Ratings
5 Comments
 

Doris Renee Brown, M.D., Ph.D.

Assistant Professor, Radiation Oncology

Research Interests

Neoplasms, Germ Cell and Embryonal; Huntington Disease; Brain Neoplasms; Carcinoma, Papillary; Neoadjuvant Therapy
More »

Contact Information

Academic: 336-713-3600 | Department: 336-713-3600

Email: drbrown@wakehealth.edu

Recent Publications

NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-year toxicity report from a phase 2 study of repeat breast-preserving surgery and 3-dimensional conformal partial-breast reirradiation for in-breast recurrence. Arthur DW, Winter KA, Kuerer HM, Haffty BG, Cuttino LW, Todor DA, Simone NL, Hayes SB, Woodward WA, McCormick B, Cohen RJ, Sahijdak WM, Canaday DJ, Brown DR, Currey AD, Fisher CM, Jagsi R, White J.. Int J Radiat Oncol Biol Phys. 2017;98(5):1028-1035.

Outcomes after mastectomy and lumpectomy in octogenarians and nonagenarians with early-stage breast cancer. Merrill AY, Brown DR, Klepin HD, Levine EA, Howard-Mcnatt M.. Am Surg. 2017;83(8):887-894.

Accelerated unilateral radiographic Huntingtonian changes following neoadjuvant chemotherapy for a nongerminomatous germ cell tumor leading to identification of occult disease in the dorsal striatum. Lucas JT Jr, Zapadka M, Houseknecht K, Buckley KS, Couture DE, Brown DR.. J Pediatr Hematol Oncol. 2016;38(2):161-162.

Intracystic papillary carcinoma of the breast: a SEER database analysis of implications for therapy. Mogal H, Brown DR, Isom S, Griffith K, Howard-McNatt M.. Breast. 2016;27():87-92.

Toxicity results of a phase 1 safety study of pioglitazone as a cytoprotective agent against radiation-induced cognitive decline [abstract]. Sullivan NA, Page BR, Peiffer AM, Isom S, Metheny-Barlow L, Brown DR, Blackstock AW, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):E595.

NRG oncology/RTOG 1014: 3 year efficacy report from a phase II study of repeat breast preserving surgery and 3D conformal partial breast re-irradiation (PBrI) for in-breast recurrence [abstract]. Arthur DW, Moughan J, Kuerer HM, Haffty BG, Cuttino LW, Todor DA, Simone NL, Hayes SB, Woodward WA, McCormick B, Cohen RJ, Sahijdak WM, Canaday DJ, Brown DR, Currey AD, Fisher CM, Jagsi R, White JR.. Int J Radiat Oncol Biol Phys. 2016;96(5):941.

Late breast toxicity rates in a prospective evaluation of radiation therapy (RT) in a multiracial/ethnic population of breast cancer (BC) patient [abstract]. Urbanic JJ, Case D, Baez-Diaz L, Brown DR, Strasser J, Enevold G, Naughton M, Weaver KE, Baglan K, Bryant D, Langefeld C, Lad T, Lee L, Rine GP, Curtis AE, Koprowski CD, Tomlinson WV, Lesser GJ, Shaw EG, Hu J.. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):E50-E51.

NRG oncology/RTOG 1014: 1-year toxicity report from a phase II study of repeat breast preserving surgery and 3D conformal partial-breast reirradiation (PBrI) for in-breast recurrence [abstract]. Arthur DW, Winter K, Kuerer HM, Haffty BG, Cuttino LW, Todor DA, Simone NL, Hayes SB, Woodward WA, McCormick B, Cohen RJ, Sahijdak WM, Canaday DJ, Brown DR, Currey AD, Fisher CM, Jagsi R, White JR.. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):S58-S59.

Oxidative DNA damage in radiation therapy related early adverse skin reactions in breast cancer [abstract]. Hu J, Nelson O, Takita C, Case D, Wright JL, Lee E, Baez-Diaz L, Brown DR, Strasser J, Enevold G, Baglan K, Bryant D, Lad T, Lee L, Rine GP, Curtis AE, Koprowski CD, Tomlinson WV, Lesser GJ, Shaw EG, Urbanic JJ.. Int J Radiat Oncol Biol Phys. 2015;93(3 Suppl):S108.

Is postmastectomy radiation therapy indicated in patients with close or positive margins? [abstract]. Bryan M, D'Agostino R, Brown D, Levine E, Howard-McNatt M.. Ann Surg Oncol. 2014;21(Suppl 2):33.

Lithium-induced cystic renal disease: sonographic features with CT and MRI correlation [abstract]. Brown D, Tchelepi H, Tublin M.. AJR Am J Roentgenol. 2012;198(5 Suppl):E629.

Screening for depression, sleep-related disturbances, and anxiety in patients with adenocarcinoma of the pancreas: a preliminary study. Boyd AD, Brown D, Henrickson C, Hampton J, Zhu B, Almani F, Ben-Josef E, Zalupski M, Simeone DM, Taylor JM, Armitage R, Riba M.. ScientificWorldJournal. 2012;2012():650707.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Assistant Professor, Radiation Oncology

Clinical Interests

Sarcoma, Hematologic Malignancies, Breast Cancer
Doris Renee Brown, M.D., Ph.D.

Doris Renee Brown, M.D., Ph.D.

Assistant Professor, Radiation Oncology

Doctor Rating

4.5 out of 5

Doris Renee Brown, M.D., Ph.D.90 Ratings
5 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.6
CP efforts to include in decisions
4.6
CP explanations of prob/condition
4.6
CP spoke using clear language
4.6
Friendliness/courtesy of CP
4.5
Likelihood of recommending CP
4.5
Patients' confidence in CP
4.6
Time CP spent with patient
4.5
Wait time at clinic
4.0



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

5/14/2018

good

3/28/2018

Wake Forest is awesome!

2/2/2018

This was 1st visit to discuss radiation treatment. Went as expected.

12/15/2017

Dr. Brown is extremely knowledgeable and is generally not rushed in her encounters with me as a patient. She does not convey much in the way of empathy. She instead seems eager to share all of her knowledge-which is very helpful, but simply listening to the patient more may help to validate the patients feelings.

10/10/2017

very good

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Wake Forest Baptist Ranked among Nation’s ‘Best Hospitals’  25 Years in a Row by U.S. News & World ReportComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.